JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics | 146 |
Total Visits Per Month
| August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | |
|---|---|---|---|---|---|---|---|
| The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics | 5 | 15 | 4 | 3 | 3 | 6 | 0 |
Top country views
| Views |
|---|
Top cities views
| Views |
|---|
